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BSTRACT
Background:
 
Previous studies have suggested that
mice passively sensitized with anti-dinitrophenol (DNP)
monoclonal IgE antibody exhibit a triphasic cutaneous
reaction with an immediate-phase response (IPR) at
1 h, a late-phase response (LPR) at 24 h and a very
late-phase reaction (vLPR) at 8 days after challenge
with 2,4-dinitrofluorobenzene. The present study was
conducted to elucidate the role of T cells in this tri-
phasic cutaneous reaction.
 
Methods:
 
Mice were passively senseitized by an intra-
venous injection of anti-DNP monoclonal IgE anti-
body. Allergic cutaneous reaction was caused by
painting an antigen on the ears of mice and measured
an enlargement of the ears.
 
Results:
 
Whereas the magnitudes of IPR and LPR in
BALB/c nu/nu T cell-deficient mice were similar to
those in BALB/c +/+ mice, vLPR was not observed in
nu/nu mice. In addition, FK 506 (3 and 5 mg/kg) and
cyclosporin A (30 and 50 mg/kg) clearly suppressed
the onset of vLPR without affecting IPR and LPR. Because
these findings suggest the participation of  T cells in the
onset of vLPR, the character of the T cells was investi-
gated by using anti-CD4 or anti-CD8 monoclonal
antibody (mAb) and interleukin (IL)-4 and IL-5 receptor
 
α
 
 chain gene-deficient mice. When mice were treated
with anti-CD4 or anti-CD8 mAb, the magnitude of the
vLPR was augmented by anti-CD4 mAb and sup-
pressed by anti-CD8 mAb, without affecting IPR and
LPR. Disruption of the IL-4 gene slightly suppressed
IPR, LPR and vLPR, but the lack of the IL-5R
 
α
 
 chain
gene did not affect these triphasic responses.
 
Conclusions:
 
The present findings suggest that vLPR is
mainly caused by CD8-positive T cells, probably Tc1
cells, and regulated by CD4-positive T cells.
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I
 
NTRODUCTION
 
To clarify the mechanism of allergic cutaneous reactions
and to investigate the remedy for allergic skin diseases,
two different kinds of mouse model were generally used.
One is caused by repeated painting of allergen on the
ear skin
 
1
 
 and the other is caused by the painting of
allergen on mice that had been passively sensitized with
large amounts of IgE antibody.
 
2
 
 Both models show
eczematic cutaneous changes and high serum IgE. In
the latter model, animals showed a triphasic cutaneous
response after challenge with antigen.
 
3
 
 The first reaction
was an immediate-phase response (IPR) at I h after
antigen challenge. The second reaction was observed
24 h after antigen challenge and was named the ‘late-
phase reaction’ (LPR). The third reaction was a very late-
phase response (vLPR) that was seen 8 days after antigen
challenge. Pharmacologic and histopathologic studies
have suggested the mechanisms of the triphasic
reaction. The IPR is mainly caused by histamine released
from sensitized mast cells
 
4
 
 and the LPR is caused by
 
Correspondence: Professor Hiroichi Nagai, Department of
Pharmacology, Gifu Pharmaceutical University, 5-6-1 Mitahora-
higashi, Gifu 502-8585, Japan. Email: nagai@gifu-pu.ac.jp
Received 22 March 2002. Accepted for publication
28 November 2002.
 32 N NAKAMURA 
 
ET AL.
pro-inflammatory cytokines.
 
5–7
 
 In addition, a previous
study has suggested the participation of T cells in the
third phase reaction, the vLPR.
 
8
 
 However, the character
of the T cells is still unclear. Therefore, the present study
was conducted to investigate the character of T cells in
the reactions of an IgE antibody mediated triphasic
cutaneous response.
 
M
 
ETHODS
 
Animals
 
Female BALB/c +/+ and BALB/c nu/nu mice (7 weeks
old) were purchased from Japan SLC (Hamamatsu,
Japan). Female interleukin (IL)-4-knockout mice were
produced from a BALB/c background in specific pyrogen-
free conditions and age-matched female BALB/c mice
(7 weeks old) were obtained from Charles River Japan
(Osaka, Japan) and used as control animals. Female
IL-5 receptor 
 
α
 
 chain-knockout mice ((129
 
×
 
BALB/c) F2
background) were prepared and maintained as des-
cribed previously
 
9
 
 and age-matched female wild-type
mice ((129
 
×
 
BALB/c) F2 background) were used as
control animals. Experiments were undertaken following
the guidelines for the care and use of experimental
animals from the Japanese Association for Laboratory
Animal Science (1987).
 
10
 
Monoclonal IgE antibody and antigen
 
Mouse monoclonal IgE antibody against dinitrophenyl
residue was prepared as reported previously.
 
2
 
 The IgE
content of the preparation, as estimated by enzyme-
linked immunosorbent assay, was 2.9 
 
µ
 
g/mL 2,4-
Dinitrofluorobenzene (DNFB) was purchased from
Nacalai Tesque (Kyoto, Japan) and was dissolved in a
mixture of acetone and olive oil (3 : 1) at a concentra-
tion of 0.15%.
 
Triphasic cutaneous reaction
 
Mice were sensitized with an intravenous injection of
1 mL IgE preparation. Twenty-four hours after sensitiza-
tion, 25 
 
µ
 
L DNFB solution was applied onto both
surfaces of both ears. Ear thickness was assessed using
a micrometer (Peacock Upright Dial Gauge; Ozaki,
Tokyo, Japan) before or after DNFB application. FK 506
(Fujisawa Pharmaceutical, Osaka, Japan) was sus-
pended in 0.5% carboxymethyl cellulose solution and
cyclosporin A (Novartis Pharma, Tokyo, Japan) was
dissolved in myglyol 812N. Both drugs were adminis-
tered twice to mice orally, 1 h before and 72 h after
DNFB application.
 
Antibodies against murine CD4 and CD8
 
The hybridoma GK1.5
 
11
 
 and 2.43
 
12
 
 (American Type
Culture Collection, Manassas, VA, USA), which produce
rat IgG2b monoclonal antibodies (mAbs) to murine
T cell CD4 and CD8 antigens, respectively, were grown
in ascitic fluid of pristane primed nude mice. The rat
IgG2b fractions were purified from ascites by sequential
(NH
 
4
 
)
 
2
 
SO
 
4
 
 precipitation and protein A separation. Anti-
bodies were resuspended in phosphate-buffered saline
(PBS) at a concentration of 5 mg/mL and stored at
–80
 
°
 
C. Almost 98% of CD4
 
+
 
 or CD8
 
+
 
 T cells were
depleted by the intravenous injection of 0.25 mL of each
antibody.
 
Histologic study
 
Mouse ears were removed 24 h or 8 days after chal-
lenge and fixed with 10% neutral formalin (Nacalai
Tesque, Kyoto, Japan). Ears were then cut into para-
sagittal slices, dehydrated and embedded in paraffin
following standard procedures. Paraffin sections were
stained with hematoxylin and eosin and assessed by light
microscopy.
 
Statistics
 
Data are expressed as the mean 
 
±
 
 SEM. In experiments
containing two experimental groups, either Student’s or
Aspin Welch’s 
 
t
 
-test was used to evaluate the statistical
significance of differences after the variances of the
data were evaluated with the 
 
F
 
-test (
 
P
 
 < 0.05). For data
including three or more experimental groups, either a
parametric or a non-parametric Dunnett’s multiple range
test was used after Bartlett’s analysis (
 
P
 
 < 0.05). Differ-
ences were considered significant when 
 
P
 
 < 0.05.
 
R
 
ESULTS
 
The change in ear thickness by the IgE-dependent
triphasic cutaneous reaction in BALB/c +/+ and nu/nu
mice is shown in Fig. 1. Typical IPR, LPR and vLPR were
observed in BALB/c +/+ mice. In BALB/c nu/nu mice,
IPR and LPR were observed similar to those seen in
BALB/c +/+ mice, but no vLPR was observed. To confirm
the participation of T cells in the vLPR, pharmacologic
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studies using the immunosuppressive drugs FK 506 and
cyclosporin A were performed (Fig. 2). Whereas neither
drug affected the IPR and LPR, both drugs significantly
suppressed the vLPR.
The next experiment was conducted to clarify the
type of T cell involved in the development of the vLPR.
In the first experiment, to clarify more detailed characteris-
tics of the T cells, the effects of anti-CD4 and anti-CD8
antibodies on this reaction were studied. The administra-
tion of anti-CD4 or anti-CD8 mAbs did not affect the
development of IPR and LPR (Fig. 3). In contrast, the anti-
CD4 antibody enhanced the vLPR and anti-CD8 antibody
 
Fig. 1
 
Time-course study of the IgE-mediated cutaneous reac-
tion in BALB/c nu/nu mice. (
 

 
), BALB/c +/+, non-sensitized
non-challenge (N-N) group; ( ), BALB/c +/+, sensitized chal-
lenge (S-C) group; (
 

 
), BALB/c nu/nu, N-N group; (
 

 
), BALB/c
nu/nu, S-C group. Data are the mean 
 
±
 
 SEM of five to six mice.
*
 
P
 
 < 0.05, ***
 
P
 
 < 0.001 between the N-N and S-C groups
(Student’s 
 
t
 
-test). 
 
†
 
P
 
 < 0.05, 
 
†††
 
P
 
 < 0.001 between the same
treatment groups (Student’s 
 
t
 
-test).
 
Fig. 2
 
Effects of FK 506 and cyclosporin A (CysA), given in mg/kg, on the IgE-mediated cutaneous reaction in BALB/c mice at
(a) 1 h, (b) 24 h and (c) 8 days. Mice received an intravenous application of anti-dinitrophenol (DNP) IgE antibody 24 h before the
skin test. Drugs (FK 506 3 and 5 mg/kg; CysA 30 and 50 mg/kg) were administered twice orally 1 h prior to and 72 h after challenge.
Data are the mean 
 
±
 
 SEM of six mice. **
 
P
 
 < 0.01 between the control group and the FK 506- or CysA-treated group (Dunnett’s test).
 
Fig. 3
 
Effects of anti-CD4 and anti-CD8 antibodies (1 mg
each) on the IgE-mediated cutaneous reaction in BALB/c mice.
Data are the mean 
 
±
 
 SEM of three to six mice. *
 
P
 
 < 0.05,
**
 
P
 
 < 0.01, ***
 
P
 
 < 0.001 compared with the 2,4-dinitro-
fluorobenzene (DNFB) group (Student’s 
 
t
 
-test). (
 

 
), vehicle;
(
 

 
), DNFB; ( ), anti-CD4 + DNFB; (
 

 
), anti-CD8 + DNFB;
(
 

 
), rat IgG + DNFB.
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suppressed the vLPR. In addition, the vLPR was prolonged
by treatment with the anti-CD4 antibody.
In histopathologic studies, inflammatory signs, includ-
ing inflammatory cell (mainly lymphocyte) infiltration,
vasodilation and the thickness of epidermal cells, decreased
after anti-CD8 antibody treatment (Fig. 4).
The next experiment was conducted to clarify the role
of T helper (Th) 2 cytokines in this reaction, so IL-4 and
IL-5R
 
α
 
 gene-deficient mice were used. As shown in
Fig. 5a, IL-4 gene-deficient mice showed slightly lowered
responses of the IPR, the LPR and the vLPR. In addition,
IL-5R
 
α
 
 gene disruption did not affect the development of
the triphasic cutaneous reaction (Fig. 5b).
In histopathologic studies, a moderate decrease in the
number of inflammatory cells (especially eosinophils) in
the skin lesion was observed in IL-5R
 
α
 
 gene-deficient
mice. However, other changes were similar between skin
lesions in wild-type and gene-deficient mice (data not
shown).
 
D
 
ISCUSSION
 
In the present study, we demonstrated the phenotypes of
the T cells in IgE-dependent triphasic skin reactions. To
confirm the role of T cells in the vLPR, T cell-deficient
(nu/nu) mice were used. No vLPR was observed in mice,
Fig. 4 Effects of anti-CD4
and anti-CD8 antibodies on
histopathologic changes caused
by the IgE-mediated cutaneous
reaction in BALB/c mice (origi-
nal magnification ×100; H&E).
DNFB, 2,4-dinitrofluorobenzene.
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whereas both the IPR and the LPR were induced, almost
equivalent to that seen in +/+ mice. Therefore, the
vLPR in IgE-dependent triphasic skin reactions is deeply
dependent on T cells.
In addition, FK 506 and cyclosporin A suppressed the
vLPR but not the IPR and the LPR. These findings confirm
the role of T cells in the vLPR.
From the above findings, we analyzed the subclass of
T cells that play a role in the vLPR. The T cells are classified
into CD4
 
+
 
 and CD8
 
+
 
 cells on the basis of differences in
their surface antigens.
 
13–15
 
 Because there is some evidence
to suggest the participation of CD4
 
+
 
 and CD8
 
+
 
 T cells in
the onset and development of allergic dermatitis,
 
15–19
 
including atopic dermatitis and psoriasis, we studied the
role of CD4
 
+
 
 and CD8
 
+
 
 T cells in IgE-dependent triphasic
skin reactions using neutralizing antibodies. When the
anti-CD4 antibody was administered, ear swelling of
the vLPR was reinforced. In addition, anti-CD8 antibody
lowered the magnitude of vLPR, whereas no effect was
observed in the first- and second-phase reactions. These
findings suggest that CD8
 
+
 
 T cells play an inflammatory
role in the onset of the vLPR and CD4
 
+
 
 T cells regulate the
vLPR. These difference concerning the role of CD8
 
+
 
 and
CD4
 
+
 
 T cells may be related to the low efficacy of FK 506
and cyclosporin A on the vLPR. The pharmacologic activity
of these two immunosuppressors on each of the CD4
 
+ and
CD8+ T cells should be investigated in the future.
There is much evidence to suggest an important role
for Th2 cells in a certain kind of allergic dermatitis, espe-
cially atopic dermatitis, including IgE production and
eczema symptoms.16,17 However, the present findings
suggest that the CD4+ T cells may have a suppressive
effect on the vLPR in IgE-dependent triphasic skin reac-
tions. From these findings, we examined the IgE-induced
triphasic cutaneous response in IL-4-deficient mice. The
present results suggest all triphasic reactions were slightly
lowered in IL-4 gene-deficient mice and IL-5Rα gene
disruption did not affect them. These findings suggest a
small role for Th2 or Tc2 in the onset of the vLPR.
In addition, although a moderate decrease in the
number of infiltrating eosinophils was observed in IL-5Rα
gene-deficient mice, the increase in ear thickness during
the vLPR was not altered. These findings suggest no direct
correlation between the number of eosinophils and ear
thickness.
In delayed-type hypersensitivity (DTH) reactions, the
participation of both CD4+ Th1 cells and CD8+ T cells
are well documented.18 However, the nature of CD8+
T cells is still obscure. There is some evidence to suggest
that CD8+ T cells, especially Tc1 cells, play an important
role in DTH mainly by interferon (IFN)-γ production, but
not cytoxic activity.19 This evidence suggests the existence
of similar mechanisms in the onset of the vLPR. Therefore,
further experiments to clarify the effect of IFN-γ neutriliz-
ing antibody or IFN-γ gene disruption on the vLPR will be
necessary.
Fig. 5 Time-course study of the IgE-mediated cutaneous reac-
tion in (a) interleukin (IL) 4-knockout, (b) IL-5 receptor α (IL-5Rα)
chain-knockout and wild-type mice. (), nonsense wild-type
mice; () sense wild-type mice; (), nonsense (a) IL-4 or
(b) IL-5Rα chain-knockout mice; (), sense (a) IL-4 or (b) IL-5Rα
chain-knockout mice. Data are the mean ± SEM of three to
six mice. *P < 0.05, **P < 0.01 compared with the wild-type
sense group (Student’s t-test).
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Regarding the similarity of spontaneous flare-up
phenomena in the human skin and the vLPR, we do not
have adequate data to make any comment. At least, we
have demonstrated a negligible vLPR in DNFB-treated
non-sensitized BALB/c +/+ mice in a previous study.3
Whereas many mechanisms may have contributed to the
onset of vLPR, CD8+ T cells, probably Tc1 cells, and IgE
play an important role in the onset of vLPR.
In the present study, we examined the role of T cells in
an IgE-dependent triphasic skin reaction. In the vLPR,
CD8+ T cells played an important role in promoting the
reaction. In addition, Th2 cells may play a minor role in
the development of the vLPR and CD4+ T cells play a reg-
ulatory role in the onset of the vLPR.
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